Report: Georgia Court of Appeals to Rule on Medical Marijuana Licensing Case

Plaintiffs failed in a separate bid to overturn the permitting decisions.

The Georgia Court of Appeals will weigh in on a lawsuit that alleges the state’s medical marijuana licensing process – which granted permits to two companies, Florida-based Trulieve and Georgia-based Botanical Sciences to manufacture and sell cannabis oils – was corrupt.

Though the plaintiffs in the suit already failed in a separate bid to overturn the permitting decisions by the state Medical Cannabis Commission, the court could still disrupt the industry if the suit is successful, Fox 5 Atlanta reported.

“The members of the Medical Cannabis Commission knew who the owners were of these companies, who the companies were affiliated with, and they scored in an arbitrary and frankly sometimes nonsensical way,” said attorney Kristen Goodman, who represents several of the five companies that joined forces in the lawsuit.

Georgia’s limited medical cannabis market – which is capped at six companies and only allows non-smokable forms of marijuana – has been slow to launch, now two years in the making. The two licensed companies were only granted permits in September this year.

But it could be months until the court of appeals issues a ruling, Fox 5 Atlanta reported, meaning the industry could be well under way by the time the court makes a decision.

John Schroyer


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 7 hours

FDA Says CBD Still Can’t Be Dietary Supplement

@GreenMarketRpt – 12 hours

Mind Cure Continues Its Winding Down Process

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.